http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104004062-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104004062-B |
| titleOfInvention | about PER2 protein agonist polypeptide and application thereof |
| abstract | The present invention relates to pharmaceutical field, be specifically related to there is promotion PER2 protein expression, the polypeptide for the treatment of esophagus cancer.Its sequence is QSSLYGDFPDLQ is brand-new sequence, and this polypeptide can promote PER2 protein expression in body, treatment esophagus cancer.Improve tumor-bearing mice survival rate in vivo; Suppress the propagation of people's esophageal cancer cell TE1, migration; There is potential new drug development value. |
| priorityDate | 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.